Major Funding Milestone: Dianosic raises 4.7M€ – February 2023


 

Dianosic raises €4.7M to bring treatment for chronic rhinitis into clinical trial. ▶︎ Click here to discover the press release.

 


Pr. Christian Debry – Philippe Bastide (CEO) – Marc Augustin (Chairman)


Share this article

Discover our other articles

Dianosic launches a WiSEED backed convertible bonds transaction to accelerate innovation in the treatment of chronic allergic rhinitis. This initiative aims to support the…
We are delighted to announce that Dianosic is one of the nominees for the 2024 edition of the “Trophées des entreprises d’Alsace”. This selection…
Nov 12, 2024 Dianosic x France Deeptech
Partners
Dianosic joins France Deeptech! 🇫🇷 🚀 We are delighted to inform you of Dianosic’s official integration into the deeptech ecosystem! A dynamic network that…